TRAVASOL 5.5% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride
NDAINJECTIONINJECTABLE
Approved
Mar 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TRAVASOL 5.5% W/ ELECTROLYTES is an intravenous amino acid solution with essential electrolytes (magnesium, potassium, sodium) designed for parenteral nutrition support. It provides nitrogen and electrolyte replenishment in patients unable to take nutrition orally or enterally. The formulation delivers balanced amino acids and minerals to support protein synthesis and metabolic homeostasis.
LOE Approaching
LOE-approaching lifecycle signals declining commercial investment and smaller team focus on managed decline and hospital contract optimization.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TRAVASOL offers stable but limited growth opportunity; roles emphasize account management, contract negotiation, and cost-containment strategy in the hospital channel. Career advancement typically requires transition to growth-stage products or shift into supply chain or reimbursement expertise.
Hospital Account ManagerSupply Chain/Contract Specialist
Worked on TRAVASOL 5.5% W/ ELECTROLYTES at Baxter? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.